3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Tuberous Sclerosis
1
Triple Negative Breast Neoplasms
1
Ovarian Neoplasms
1
Fallopian Tube Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
Nivolumab
21
cabozantinib
12
Specimen Handling
11
Ipilimumab
10
belzutifan
9
pembrolizumab
8
Magnetic Resonance Spectroscopy
8
CTLA-4 Antigen
5
Biopsy
5
Axitinib
5
lenvatinib
4
Sunitinib
4
Immunoglobulin G
3
Disulfides
3
zimberelimab
2
tivozanib
2
relatlimab
2
pazopanib
2
palbociclib
2
atezolizumab
2
aldesleukin
2
X-Rays
2
Watchful Waiting
2
Radiosurgery
2
Nephrectomy
2
Bevacizumab
2
ulixertinib
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
trametinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Renal Cell
×
Propranolol
×
30 days
×
Clear all
No trials found.